Viyash Scientific balance sheet

As of Mar 2026

Total assets: ₹4,628cr+188.9% on Mar 2025
Shareholders' equity: ₹3,115cr+304.3% on Mar 2025
Total debt: ₹436cr−2.4% on Mar 2025
Cash and investments: ₹256cr+307.8% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	1,138	232	249	301
	68.7	15.1	11.1	51.4
	869	249	235	240
	96.3	106	56.9	64.5
	1.7	0.6	4.9	3.9
	0.0	0.0	0.9	0.0
	22.2	10.5	12.3	16.3
	22.2	10.5	13.2	16.3
	83.4	103	78.4	45.4
	94.9	13.3	69.6	17.0
	2,374	728	718	739
	803	385	346	346
	0.1	0.1	2.6	0.0
	1,045	363	336	341
	256	62.7	64.8	41.6
	14.0	6.4	5.0	0.2
	0.1	0.2	0.1	0.3
	2.0	1.1	1.9	1.1
	1,317	434	410	384
	130	53.7	54.2	46.0
	2,255	873	811	780
	0.0	0.8	11.9	10.1
	4,628	1,602	1,540	1,529
Equity
	87.4	50.1	49.9	49.9
	2,824	654	607	649
	2,911	704	657	699
	204	65.9	56.4	50.4
	3,115	770	713	749
Liabilities
	302	274	143	183
	39.5	26.3	29.1	37.0
	342	300	172	220
	40.3	22.7	21.7	21.5
	32.8	3.7	6.9	12.3
	153	0.0	0.0	0.4
	568	327	200	254
	134	173	309	215
	597	257	260	244
	105	32.3	12.9	19.8
	836	462	582	479
	15.7	7.6	8.0	16.4
	24.1	11.9	3.3	6.3
	69.7	24.1	33.9	24.1
	946	505	627	526
	1,514	832	827	780
	4,628	1,602	1,540	1,529
Assets — additional as-filed lines
	4.7	0.3	0.4	3.6
Trade payables — MSME split
	36.2	0.0	—	—
	561	257	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

VIYASH₹224.55

Viyash Scientific Ltd.

· Pharma & Health

₹ CrorePeersAARTIDRUGS YATHARTH THYROCARE SUPRIYA STAR SPARC SHILPAMED RUBICONMcap ₹9,809 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	300.7	248.6	231.6	1,137.9	1,137.9
+ Capital Work-in-Progress	51.4	11.1	15.1	68.7	68.7
+ Goodwill	240.0	234.9	248.8	868.7	868.7
+ Other Intangibles	64.5	56.9	105.6	96.3	96.3
+ Intangibles under Development	3.9	4.9	0.6	1.7	1.7
+ Non-current Investments	0.0	0.9	0.0	0.0	0.0
+ Other Non-current Financial Assets	16.3	12.3	10.5	22.2	22.2
Non-current Financial Assets	16.3	13.2	10.5	22.2	22.2
+ Deferred Tax Assets	45.4	78.4	102.7	83.4	83.4
+ Other Non-current Assets	17.0	69.6	13.3	94.9	94.9
Total Non-current Assets	739.2	717.5	728.2	2,373.8	2,373.8
Current Assets
+ Inventories	346.1	346.2	385.3	803.2	803.2
+ Current Investments	0.0	2.6	0.1	0.1	0.1
+ Trade Receivables	341.0	335.6	363.2	1,045.2	1,045.2
+ Cash & Cash Equivalents	41.6	64.8	62.7	255.8	255.8
+ Other Bank Balances	0.2	5.0	6.4	14.0	14.0
+ Short-term Loans	0.3	0.1	0.2	0.1	0.1
+ Other Current Financial Assets	1.1	1.9	1.1	2.0	2.0
Current Financial Assets	384.2	410.1	433.6	1,317.1	1,317.1
+ Other Current Assets	46.0	54.2	53.7	129.5	129.5
Total Current Assets	779.8	810.9	872.9	2,254.6	2,254.6
+ Assets Held for Sale	10.1	11.9	0.8	0.0	0.0
Total Assets	1,529.1	1,540.4	1,602.0	4,628.4	4,628.4
Equity
+ Equity Share Capital	49.9	49.9	50.1	87.4	87.4
+ Other Equity / Reserves	648.9	606.7	654.4	2,823.7	2,823.7
Equity — Owners of Parent	698.8	656.6	704.5	2,911.1	2,911.1
+ Minority Interest	50.4	56.4	65.9	203.7	203.7
Total Equity	749.2	713.0	770.4	3,114.7	3,114.7
Liabilities
+ Borrowings — Non-current	182.8	142.7	273.9	302.1	302.1
+ Other Non-current Financial Liab	37.0	29.1	26.3	39.5	39.5
Non-current Financial Liabilities	219.8	171.8	300.2	341.6	341.6
+ Provisions — Non-current	21.5	21.7	22.7	40.3	40.3
+ Deferred Tax Liabilities	12.3	6.9	3.7	32.8	32.8
+ Other Non-current Liabilities	0.4	0.0	0.0	153.1	153.1
Non-current Liabilities	253.9	200.4	326.6	567.8	567.8
+ Borrowings — Current	215.1	308.6	172.5	133.7	133.7
+ Trade Payables	244.3	260.3	256.7	597.3	597.3
+ Other Current Financial Liab	19.8	12.9	32.3	105.4	105.4
Current Financial Liabilities	479.2	581.8	461.5	836.4	836.4
+ Provisions — Current	16.4	8.0	7.6	15.7	15.7
+ Current Tax Liabilities	6.3	3.3	11.9	24.1	24.1
+ Other Current Liabilities	24.1	33.9	24.1	69.7	69.7
Current Liabilities	526.1	627.0	505.0	945.9	945.9
Total Liabilities	779.9	827.4	831.6	1,513.7	1,513.7
Total Equity & Liabilities	1,529.1	1,540.4	1,602.0	4,628.4	4,628.4
Assets — additional as-filed lines
+ Current Tax Assets	3.6	0.4	0.3	4.7	4.7
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	0.0	36.2	36.2
+ Dues to Other Creditors — Current	—	—	256.7	561.1	561.1

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.